A new and clinically relevant murine model of solid-organ transplant aspergillosis

DMM Disease Models and Mechanisms

Volumn 6, Issue 3, 2013, Pages 643-651

  Herbst, Susanne ^a   Shah, Anand ^a,b   Carby, Martin ^b   Chusney, Gary ^c   Kikkeri, Naresh ^c   Dorling, Anthony ^d   Bignell, Elaine ^a   Shaunak, Sunil ^a   Armstrong James, Darius ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; FUNGUS GROWTH; HISTOPATHOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INOCULATION; INVASIVE ASPERGILLOSIS; LUNG ALVEOLUS MACROPHAGE; LUNG ASPERGILLOSIS; LUNG TRANSPLANTATION; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TRACHEOBRONCHITIS;

ANIMALS; ASPERGILLUS FUMIGATUS; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROCORTISONE; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; INTERLEUKIN-8; LUNG TRANSPLANTATION; MALE; MICE; PNEUMONIA; PULMONARY ASPERGILLOSIS; RISK FACTORS; STEROIDS; SURVIVAL ANALYSIS; TACROLIMUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84877839151     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.010330     Document Type: Article

References (33)

1. Aramburu, J., Heitman, J. and Crabtree, G. R. (2004). Calcineurin: a central controller of signalling in eukaryotes. EMBO Rep. 5, 343-348.
2. Baddley, J. W., Andes, D. R., Marr, K. A., Kontoyiannis, D. P., Alexander, B. D., Kauffman, C. A., Oster, R. A., Anaissie, E. J., Walsh, T. J., Schuster, M. G. et al. (2010). Factors associated with mortality in transplant patients with invasive aspergillosis. Clin. Infect. Dis. 50, 1559-1567.
3. Barratt, R. W., Johnson, G. B. and Ogata, W. N. (1965). Wild-type and mutant stocks of Aspergillus nidulans. Genetics 52, 233-246.
4. De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A. et al. (2008). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46, 1813-1821.
5. Fishman, J. A. (2007). Infection in solid-organ transplant recipients. N. Engl. J. Med. 357, 2601-2614.
6. Fishman, J. A. (2011). Infections in immunocompromised hosts and organ transplant recipients: essentials. Liver Transpl. 17 Suppl. 3, S34-S37.
7. Foor, F., Parent, S. A., Morin, N., Dahl, A. M., Ramadan, N., Chrebet, G., Bostian, K. A. and Nielsen, J. B. (1992). Calcineurin mediates inhibition by FK506 and cyclosporin of recovery from alpha-factor arrest in yeast. Nature 360, 682-684.
8. Fox, D. S. and Heitman, J. (2002). Good fungi gone bad: the corruption of calcineurin. Bioessays 24, 894-903.
9. Green, C. J. and Allison, A. C. (1978). Extensive prolongation of rabbit kidney allograft survival after short-term cyclosporin-A treatment. Lancet 311, 1182-1183.
10. Greenblatt, M. B., Aliprantis, A., Hu, B. and Glimcher, L. H. (2010). Calcineurin regulates innate antifungal immunity in neutrophils. J. Exp. Med. 207, 923-931.
11. Heitman, J., Cardenas, M. E., Breuder, T., Hemenway, C., Muir, R. S., Lim, E., Goetz, L., Zhu, D., Lorenz, M. and Dolinski, K. (1994). Antifungal effects of cyclosporine and FK 506 are mediated via immunophilin-dependent calcineurin inhibition. Transplant. Proc. 26, 2833-2834.
12. High, K. P. and Washburn, R. G. (1997). Invasive aspergillosis in mice immunosuppressed with cyclosporin A, tacrolimus (FK506), or sirolimus (rapamycin). J. Infect. Dis. 175, 222-225.
13. Kang, Y. J., Kusler, B., Otsuka, M., Hughes, M., Suzuki, N., Suzuki, S., Yeh, W. C., Akira, S., Han, J. and Jones, P. P. (2007). Calcineurin negatively regulates TLR-mediated activation pathways. J. Immunol. 179, 4598-4607.
14. Kotton, C. N. and Fishman, J. A. (2005). Viral infection in the renal transplant recipient. J. Am. Soc. Nephrol. 16, 1758-1774.
15. Kramer, M. R., Denning, D. W., Marshall, S. E., Ross, D. J., Berry, G., Lewiston, N. J., Stevens, D. A. and Theodore, J. (1991). Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis. Am. Rev. Respir. Dis. 144, 552-556.
16. Marchetti, O., Moreillon, P., Glauser, M. P., Bille, J. and Sanglard, D. (2000). Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob. Agents Chemother. 44, 2373-2381.
17. Medawar, P. B. (1958). The immunology of transplantation. In The Harvey Lectures (1956-1957), series 52, pp.144-176. New York: Academic Press.
18. Moore, R. and Lord, R. (1994). Tacrolimus (FK506) versus cyclosporin in prevention of liver allograft rejection. Lancet 344, 948.
19. National Committee for Clinical Laboratory Standards (2002). Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard. NCCLS document M38-A. Clinical and Laboratory Standards Institute, Villanova, PA.
20. Ochiai, T., Nakajima, K., Nagata, M., Suzuki, T., Asano, T., Uematsu, T., Goto, T., Hori, S., Kenmochi, T., Nakagoori, T. et al. (1987). Effect of a new immunosuppressive agent, FK 506, on heterotopic cardiac allotransplantation in the rat. Transplant. Proc. 19, 1284-1286.
21. Odom, A., Muir, S., Lim, E., Toffaletti, D. L., Perfect, J. and Heitman, J. (1997). Calcineurin is required for virulence of Cryptococcus neoformans. EMBO J. 16, 2576-2589.
22. Pappas, P. G., Alexander, B. D., Andes, D. R., Hadley, S., Kauffman, C. A., Freifeld, A., Anaissie, E. J., Brumble, L. M., Herwaldt, L., Ito, J. et al. (2010). Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis. 50, 1101-1111.
23. Rüegger, A., Kuhn, M., Lichti, H., Loosli, H. R., Huguenin, R., Quiquerez, C. and von Wartburg, A. (1976). [Cyclosporin A, a peptide metabolite from Trichoderma polysporum (Link ex Pers.) Rifai, with a remarkable immunosuppressive activity]. Helv. Chim. Acta 59, 1075-1092.
24. Sheppard, D. C., Graybill, J. R., Najvar, L. K., Chiang, L. Y., Doedt, T., Kirkpatrick, W. R., Bocanegra, R., Vallor, A. C., Patterson, T. F. and Filler, S. G. (2006). Standardization of an experimental murine model of invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 50, 3501-3503.
25. Steinbach, W. J., Singh, N., Miller, J. L., Benjamin, D. K., Jr, Schell, W. A., Heitman, J. and Perfect, J. R. (2004). In vitro interactions between antifungals and immunosuppressants against Aspergillus fumigatus isolates from transplant and nontransplant patients. Antimicrob. Agents Chemother. 48, 4922-4925.
26. Steinbach, W. J., Reedy, J. L., Cramer, R. A., Jr, Perfect, J. R. and Heitman, J. (2007a). Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat. Rev. Microbiol. 5, 418-430.
27. Steinbach, W. J., Cramer, R. A., Jr, Perfect, B. Z., Henn, C., Nielsen, K., Heitman, J. and Perfect, J. R. (2007b). Calcineurin inhibition or mutation enhances cell wall inhibitors against Aspergillus fumigatus. Antimicrob. Agents Chemother. 51, 2979-2981.
28. Subcommittee on Antifungal Susceptibility Testing of the ESCMID European Committee for Antimicrobial Susceptibility Testing (2008). EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds. Clin. Microbiol. Infect. 14, 982-984.
29. Tamura, K., Fujimura, T., Iwasaki, K., Sakuma, S., Fujitsu, T., Nakamura, K., Shimomura, K., Kuno, T., Tanaka, C. and Kobayashi, M. (1994). Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin. Biochem. Biophys. Res. Commun. 202, 437-443.
30. Tang, C. M., Cohen, J., Krausz, T., Van Noorden, S. and Holden, D. W. (1993). The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis. Infect. Immun. 61, 1650-1656.
31. Watson, C. J. and Dark, J. H. (2012). Organ transplantation: historical perspective and current practice. Br. J. Anaesth. 108 Suppl. 1, i29-i42.
32. Werner, J. L., Metz, A. E., Horn, D., Schoeb, T. R., Hewitt, M. M., Schwiebert, L. M., Faro-Trindade, I., Brown, G. D. and Steele, C. (2009). Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol. 182, 4938-4946.
33. White, P. L., Linton, C. J., Perry, M. D., Johnson, E. M. and Barnes, R. A. (2006). The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting. Clin. Infect. Dis. 42, 479-486.